Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

U.S. patent for HCV vaccine granted to Innogenetics

Jan. 27, 2000

U.S. patent issues for Ribozyme's hepatitis B virus ribozyme

Jan. 26, 2000

Revised labeling for Propulsid prompted by continuing reports of cardiac adverse events

Jan. 26, 2000

FDA accepts InKine's Diacol NDA for filing

Jan. 26, 2000

Licensing opportunity from NIH: modified HCV peptide vaccine

Jan. 26, 2000

Methylnaltrexone reverses opioid-induced constipation

Jan. 25, 2000

Enhancement of both upper and lower GI motility associated with selective 5-HT4 agonist

Jan. 21, 2000

FDA approves two-dose regimen of Merck & Co.'s Recombivax HB for adolescent use

Jan. 21, 2000

Medeva's Hepagene study shows promising results as treatment of chronic HBV

Jan. 21, 2000

Enzo Biochem receives grant for HBV therapy

Jan. 19, 2000

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...